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Background: Metabolic syndrome (MetSyn) is an important risk factor for cardiovascular diseases and type 2
diabetes. It is unknown whether the MetSyn prevalence differs within a homogenous population residing in
different settings in Africa and Europe. We therefore assessed the prevalence of MetSyn among Ghanaians
living in rural- and urban-Ghana and Ghanaian migrants living in Europe. Methods: We used data from the
cross-sectional multi-centre RODAM study that was conducted among Ghanaian adults aged 25–70 years
residing in rural- and urban-Ghana and in London, Amsterdam and Berlin (n=5659). MetSyn was defined
according to the 2009 harmonized definition. Geographical locations were compared using age-standardized
prevalence rates, and prevalence ratios (PRs), adjusted for age, education, physical activity, and smoking and
stratified for sex. Results: In men, the age-standardized prevalence of MetSyn was 8.3% in rural Ghana and
showed a positive gradient through urban Ghana (23.6%, adjusted PR=1.85, 95% confidence interval 1.17–
2.92) to Europe, with the highest prevalence in Amsterdam (31.4%; PR= 4.45, 2.94–6.75). In women, there was
a rural-to-urban gradient in age-standardized MetSyn prevalence (rural Ghana 25%, urban Ghana 34.4%,
PR= 1.38, 1.13–1.68), but small differences in MetSyn prevalence between urban-Ghanaian and European-
Ghanaian women (Amsterdam 38.4%; London 38.2%). Conclusion: MetSyn is highly prevalent in Ghana as well
as in Ghanaian migrants in Europe. To assist prevention efforts, further research is needed to understand the
mechanisms driving the geographical differences in MetSyn prevalence between migrant and non-migrant
Ghanaians.
. .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . .
Introduction
Metabolic syndrome (MetSyn) is a collection of five cardiometabolicrisk factors including an increased waist circumference (WC),
elevated triglyceride levels, lowered high-density lipoprotein cholesterol
(HDL-C), elevated blood pressure (BP) and raised fasting plasma
glucose (FPG).1 Compared with individuals without the syndrome, in-
dividuals with MetSyn have a 3- to 5-fold increased risk for developing
type 2 diabetes (T2D)2,3 and a doubled risk for cardiovascular disease
(CVD) events.4 Studies on MetSyn in sub-Saharan African (SSA)
countries are scarce, but suggest that MetSyn is of importance in this
region, with prevalence rates varying from 13.7% in rural Uganda5 to
21% in urban Ghana6 and 34.6% in urban Kenya.7 Rapid urbanization
associated with lifestyle changes have been suggested as a major con-
tributor to this rural–urban difference.8 Data on MetSyn prevalence
among populations with SSA origin in high-income countries are also
limited and show substantial differences in MetSyn prevalence,
depending on sex and geographical location of residence.9,10 There is
no clear explanation for these differences in MetSyn prevalence, but this
might be due to differential exposures in the countries of settlement,
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leading to variation in distribution and clustering of MetSyn
components.11 As MetSyn is an important risk factor for CVD and
T2D, it is important to obtain more insight into the distribution of
MetSyn components among SSA populations and how this varies
between populations from SSA origins in different settings. Therefore,
the aim of this study was to assess whether the prevalence of MetSyn and
its individual components differ among Ghanaian migrants in urban
areas in The Netherlands, UK and Germany and in their counterparts
living in rural and urban Ghana.
Methods
The rationale, conceptual framework, design and methodology of
the RODAM study have previously been described elsewhere,12
and will be summarized here.
Study population and study design
The RODAM study, a multi-centre, cross-sectional study, was
carried out between 2012 and 2015, and included Ghanaians
aged 25 years living in rural and urban Ghana, and in the
cities of London, Amsterdam and Berlin. Ghanaians are one of
the largest SSA migrant groups in the UK, Netherlands and
Germany, of whom the majority resides in their respective
capital cities.13–15 Various recruitment strategies were
necessary at the different study sites, due to differences in
population registration systems across European countries and
in Ghana. In brief, in a random sampling procedure, participants
were drawn from rural or urban enumeration areas in Ghana, or
from municipality registration and Ghanaian organizations in
the three European sites. In Ghana, the participation rate was
76% at the rural and 74% at the urban recruitment sites. In
Europe, the participation rates were 53% in Amsterdam, 75%
in London and 68% in Berlin.
Data collection, measurements and definitions
Data collection was standardized using standard operation procedures
across all sites. Information on demographics, socioeconomic
position, migration-related factors, health status and health
behaviour was obtained using questionnaires either self-administered
or via interviews conducted by trained interviewers. Age showed a
normal distribution, and was therefore presented as continuous
variable. Education was used as a proxy for socioeconomic position,
and was categorized into none or elementary schooling, lower
secondary, higher secondary and tertiary education, or unknown
level. First generation migrant was defined as being born in Ghana
and migrated to Europe. Smoking status was categorized into current
or former smoker, or never smoked. The World Health Organization
STEPS questionnaire16 was used to derive physical activity in
metabolic equivalent (MET, hours/week), which included physical
activity at work, while commuting and in leisure time.17 Answers
were subsequently classified based on the guidelines of The IPAQ
group,18 into low, moderate or high level of physical activity.
Physical examinations were performed with validated devices.
Weight and height were measured in light clothing without shoes
using the SECA877 weighing scale and SECA217 portable
stadiometer. WC was measured using measuring tape at the
midpoint between the lower rib and the upper margin of the iliac
crest. All anthropometric measurements were performed twice by
the same examiner and the average of the two measurements was
used for analysis. BP was measured three times after at least 5 min
rest, in sitting position with an appropriate cuff, using Microlife
WatchBP home, a semi-automated device. The mean of the last
two measurements was used in the analysis.
Participants were instructed to fast from 10:00p.m. the night prior
to the blood sample collection.
Fasting venous blood samples were collected by trained research
assistants. Processing and transportation of the blood samples was
standardized across all study sites.12 FPG, HDL-cholesterol and tri-
glycerides were determined using the ABX Pentra 400 chemistry
analyser (HORIBA ABX, Montpellier, France).
MetSyn was determined using the definition of International
Diabetes Federation in collaboration with the National Heart,
Lung, and Blood Institute, American Heart Association, World
Heart Federation, International Atherosclerosis Society and
International Association for the Study of Obesity.1 This
definition identifies an individual with MetSyn if at least three of
the following five criteria are present: elevated WC or abdominal
obesity (men 94 cm, women 80 cm); elevated triglycerides
(1.7 mmol/l and/or the use of lipid-lowering medication);
reduced HDL-cholesterol (men <1.0 mmol/l, women <1.3 mmol/l,
and/or the use of lipid-lowering medication); elevated BP (systolic
130 and/or diastolic 85 mmHg, and/or antihypertensive
treatment); raised FPG (5.6 mmol/l and/or the use of blood
glucose-lowering medication).
Statistical analysis
Participants aged 25–70 years were eligible for inclusion. 6385
Ghanaians agreed to participate in the study of which 5898
completed physical examination and provided blood samples for bio-
chemical characterization. After exclusion of participants outside the
age range, 5659 participants were included in the analysis.
All analyses were stratified by geographical location and sex. Age-
standardized prevalence rates of MetSyn and its components were
calculated using the age distribution of the total RODAM
population as standard population. Prevalence ratios (PRs) with cor-
responding 95% confidence intervals (CI) were calculated using
Poisson regression with model-based variance to compare the
prevalence of MetSyn between the study sites.10,19 As the RODAM
study conceptualized rural Ghana as the source from where
Ghanaians migrated to urban Ghana and subsequently to Europe,
we used rural Ghana as the reference category. In the Poisson
regression analysis, adjustment was made for covariates in two
models. Model 1 was adjusted for age and level of education; model
2 for age, level of education, physical activity and smoking status.10
The prevalence rates of MetSyn and its components were compared
between the European sites, as this would potentially disclose differ-
ences between the populations of the three European study sites.
Amsterdam was used as the reference population for the within-
Europe comparison, as the population of this study location
previously showed to have the highest prevalence of impaired fasting
glucose.19 The analysis for the European sites was adjusted for the
factors included in model 2 plus length of stay in Europe (in years).
Analyses were performed using IBM SPSS Statistics (SPSS Inc.,
Released 2016. SPSS for Windows, Version 24.0, Chicago, IL, USA).
Age-standardized prevalence was calculated using R Statistics (R
Core Team. 2017, R for Windows, version 3.4.1. R Foundation for
Statistical Computing, Vienna, Austria).
Ethical approval and consent to participate
Ethical approval of the study was requested from the respective ethics
committees in Ghana (School of Medical Sciences/Komfo Anokye
Teaching Hospital Committee on Human Research, Publication &
Ethical Review Board), the Netherlands (Institutional Review Board
of the Academic Medical Center, University of Amsterdam), Germany
(Ethics Committee of Charite´-Universita¨tsmedizin Berlin) and the UK
(London School of Hygiene and Tropical Medicine Research Ethics
Committee) before data collection began in each country. Informed
written consent was obtained from each participant prior to the
enrolment in the study.
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Results
Characteristics of study population
A total of 5659 participants were eligible for analysis, of which 62.3%
were women. Table 1 shows detailed population characteristics of
the included participants. The mean age of the sample was
46.2 years. Amsterdam-Ghanaian men, and London- and rural-
Ghanaian women were older compared with participants in other
sites. Ghanaians living in London were the most educated
population. Ninety-seven percent of the European-Ghanaians were
first generation migrants. Smoking prevalence was low in all
locations, except among Berlin-Ghanaian men. Ghanaians living in
London were least physically active.
Prevalence of MetSyn
In men, the age-standardized MetSyn prevalence ranged from 8%
(95% CI, 5.5–12.1) among rural-Ghanaians to 31% (27.0–36.3)
among Amsterdam-Ghanaians, with a positive gradient in
prevalence through urban Ghana to European sites (figure 1A).
This positive gradient was also observed between rural- and
urban-Ghanaian women [rural Ghana 25% (21.4–29.6), urban
Ghana 34% (30.8–38.3)], but not between urban-Ghanaian and
European-Ghanaian women (figure 1B). The adjusted PR of
MetSyn was almost two times higher for urban-Ghanaian men
compared with rural-Ghanaian men, and increased to a more than
four times higher PR in Amsterdam-Ghanaian men (figure 2).
Among women, PRs did not vary greatly between the sites
(figure 3), except for Berlin-Ghanaian women, who had a lower
PR compared with the urban-Ghanaian and the other European
sites. Comparison between the European sites, with additional
adjustment for length of stay in Europe, strengthened the trend
towards a lower MetSyn PR in Berlin- compared with
Amsterdam-Ghanaians (Supplementary figure S1).
Prevalence of MetSyn components
As the PRs for the MetSyn components did not vary between model
1 and model 2, only the results for model 2 are presented.
Abdominal obesity
In men, the age-standardized prevalence of abdominal obesity
showed a positive rural–urban-Europe gradient (figure 1A). In
women, abdominal obesity was highly prevalent at all sites, and
showed a prevalence gradient between rural and urban Ghana, but
not between urban Ghana and Europe (figure 1B). This was reflected
in the PRs, which showed a positive rural–urban-Europe gradient in
men (figure 2), but no difference between urban Ghana and Europe
in women, compared with rural Ghana (figure 3). Moreover, the PRs
did not differ between the European sites (Supplementary figure S1).
Elevated triglycerides
In men, the age-adjusted prevalence of elevated triglycerides did not
vary between the locations, but a trend towards a higher prevalence
in urban- and European-Ghanaians could be observed (figure 1A).
In women, the prevalence tended to be higher in rural- and urban-
Ghanaian women than in European-Ghanaian women (figure 1B).
Compared with rural-Ghanaian men, the adjusted PRs were twice
as high in Amsterdam- and London-Ghanaian men, and comparable
with urban- and Berlin-Ghanaian men. This was also reflected in the
comparison of PRs between the European sites, which showed a
lower PR for elevated triglycerides in Berlin- compared with
Amsterdam-Ghanaian men (Supplementary Figure S1). In women,
the PRs for elevated triglycerides were similar between study sites,
with a trend towards lower PRs in Amsterdam and Berlin compared
with rural Ghana (figure 3).
Table 1 Population characteristics by locality and sex
Rural-Ghanaians Urban-Ghanaians Amsterdam-Ghanaians Berlin-Ghanaians London-Ghanaians
Men, n (%) 405 (19.0) 415 (19.4) 609 (28.5) 297 (13.9) 410 (19.2)
Age, years (CI) 46.2 (45.0–47.5) 46.5 (45.4–47.7) 48.4 (47.7–49.2) 45.8 (44.5–47.1) 46.1 (45.0–47.1)
Education level, % (CI)
None or elementary 39.0 (34.4–43.8) 22.2 (18.4–26.3) 20.5 (17.5–23.9) 6.1 (3.8–9.2) 3.9 (2.3–6.1)
Lower secondary 36.0 (31.5–40.8) 42.4 (37.7–47.2) 40.6 (36.7–44.5) 47.8 (42.2–53.5) 24.9 (20.9–29.2)
Higher secondary 13.3 (10.3–16.9) 20.5 (16.8–24.6) 25.1 (21.8–28.7) 28.3 (23.4–33.6) 16.8 (13.4–20.7)
Tertiary 5.7 (3.7–8.3) 9.2 (6.7–12.2) 8.2 (6.2–10.6) 17.5 (13.5–22.1) 41.0 (36.3–45.8)
Unknown 5.9 (3.9–8.5) 5.8 (3.8–8.3) 5.6 (4.0–7.6) 0.3 (0.0–1.6) 13.4 (10.4–17.0)
Duration of stay in Europe, years (CI) n/a n/a 18.7 (18.0–19.4) 16.8 (15.5–18.2) 15.1 (14.1–16.1)
First generation migrant, % (CI) n/a n/a 98.6 (97.3–99.3) 99.3 (97.9–99.9) 98.6 (97.0–99.5)
Current smoking, yes, % (CI) 5.8 (3.8–8.5) 3.3 (1.9–5.4) 8.1 (6.1–10.6) 14.8 (11.1–19.2) 1.3 (0.5–2.9)
Physical activity, % (CI)
Low level 10.8 (7.9–14.2) 22.4 (18.5–26.7) 20.6 (16.8–24.8) 24.2 (19.6–29.3) 41.4 (36.5–46.5)
Moderate level 16.5 (13.1–20.5) 18.6 (15.0–22.6) 14.5 (11.3–18.2) 20.9 (16.5–25.8) 18.3 (14.6–22.4)
High level 71.9 (67.3–76.3) 57.5 (52.6–62.3) 59.3 (54.4–64.1) 52.2 (46.5–57.8) 31.2 (26.6–36.0)
Women, n (%) 638 (18.1) 1034 (29.3) 931 (26.4) 250 (7.1) 670 (19.0)
Age, years (CI) 46.7 (45.7–47.6) 44.7 (44.0–45.4) 45.6 (45.0–46.1) 44.7 (43.5–45.9) 47.7 (46.9–48.5)
Education level, % (CI)
None or elementary 62.2 (58.4–65.9) 50.5 (47.4–53.5) 40.9 (37.7–44.0) 11.6 (8.1–16.0) 10.0 (7.9–12.4)
Lower secondary 25.9 (22.6–29.4) 35.9 (33.0–38.8) 30.6 (27.7–33.7) 54.0 (47.8–60.1) 29.9 (26.5–33.4)
Higher secondary 3.0 (1.9–4.5) 8.5 (6.9–10.3) 17.8 (15.5–20.4) 24.8 (19.8–30.4) 24.2 (21.1–27.5)
Tertiary 1.9 (1.0–3.2) 2.7 (1.8–3.8) 3.8 (2.7–5.1) 7.6 (4.8–11.4) 22.1 (19.1–25.3)
Unknown 7.1 (5.3–9.2) 2.4 (1.6–3.5) 6.9 (5.4–8.6) 2.0 (0.8–4.3) 13.9 (11.4–16.7)
Duration of stay in Europe, years (CI) n/a n/a 17.7 (17.2–18.2) 16.9 (15.7–18.2) 17.4 (16.5–18.3)
First generation migrant, % (CI) n/a n/a 99.5 (98.9–99.8) 99.6 (98.1–100.0) 96.9 (95.3–98.1)
Current smoking, yes, % (CI) 0 (0.0) 0.1 (0.0–0.5) 2.1 (1.3–3.2) 3.3 (1.5–6.0) 0.2 (0.0–0.8)
Physical activity, % (CI)
Low level 23.2 (20.0–26.8) 40.4 (37.4–43.4) 16.5 (13.8–19.5) 31.3 (25.8–37.3) 41.6 (37.7–45.5)
Moderate level 23.1 (19.8–26.6) 15.7 (13.6–18.1) 21.8 (18.8–25.1) 18.3 (13.8–23.5) 23.8 (20.6–27.3)
High level 53.5 (49.5–57.5) 43.2 (40.2–46.3) 55.8 (52.0–59.6) 45.5 (39.4–51.8) 24.8 (21.5–28.3)
Notes: Values are means or percentages with corresponding 95% confidence intervals. n, number; n/a, not available; CI, confidence interval.
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26.0 (21.1-31.6)
B
0 10 20 30 40 50 60 70 80 90 100
Prevalence, %
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26.3 (20.2-33.9)
39.2 (33.6-43.3)
58.5 (52.6-64.9)
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9.2 (7.3-11.7)
7.7 (4.5-12.4)
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37.9 (33.8-42.4)
30.1 (23.6-38.0)
39.5 (34.8-44.8)
37.4 (32.7-42.5)
45.0 (40.9-49.4)
62.2 (57.1-67.6)
64.3 (54.4-75.5)
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19.1 (16.5-22.1)
30.1 (26.4-34.2)
13.7 (9.3-19.6)
19.1 (15.9-22.7)
Figure 1 Age-standardized prevalence of metabolic syndrome, abdominal obesity, elevated triglycerides, reduced high-density lipoprotein
cholesterol (HDL-C), elevated blood pressure and elevated fasting plasma glucose, by site in men (A) and women (B). Error bars are 95%
confidence intervals
4 European Journal of Public Health
D
ow
nloaded from
 https://academ
ic.oup.com
/eurpub/advance-article-abstract/doi/10.1093/eurpub/ckz051/5435721 by London School of H
ygiene & Tropical M
edicine user on 01 July 2019
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Metabolic syndrome PR (95% CI)
Urban-Ghanaian 1.38 (1.13-1.68)
Amsterdam-Ghanaian 1.54 (1.24-1.92)
Berlin-Ghanaian 1.12 (0.82-1.52)
London-Ghanaian 1.54 (1.22-1.95)
Abdominal obesity 
Urban-Ghanaian 1.43 (1.26-1.63)
Amsterdam-Ghanaian 1.59 (1.39-1.82)    
Berlin-Ghanaian 1.57 (1.32-1.88)
London-Ghanaian 1.61 (1.38-1.87)
Elevated triglycerides 
Urban-Ghanaian 1.14 (0.85-1.52)
Amsterdam-Ghanaian 0.78 (0.54-1.15)    
Berlin-Ghanaian 0.61 (0.35-1.07)
London-Ghanaian 1.03 (0.71-1.50)
Reduced HDL-C 
Urban-Ghanaian 0.87 (0.76-0.99)
Amsterdam-Ghanaian 0.58 (0.48-0.69)    
Berlin-Ghanaian 0.49 (0.38-0.64)
London-Ghanaian 0.66 (0.55-0.80)
Elevated blood pressure 
Urban-Ghanaian 1.23 (1.04-1.45)
Amsterdam-Ghanaian 1.78 (1.50-2.12)    
Berlin-Ghanaian 1.94 (1.56-2.41)
London-Ghanaian 1.89 (1.57-2.27)
Raised fasting glucose 
Urban-Ghanaian 1.31 (1.01-1.70)
Amsterdam-Ghanaian 1.99 (1.51-2.60)
Berlin-Ghanaian 0.88 (0.58-1.36)
London-Ghanaian 1.20 (0.88-1.65)
Figure 3 Prevalence ratios for metabolic syndrome and its components for women by site, compared with rural Ghana (reference population,
PR=1.00). Error bars are 95% confidence intervals. Model adjusted for age, level of education, physical activity and smoking status
0.01 0.10 1.00 10.00
Metabolic syndrome PR (95% CI)
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London-Ghanaian 3.49 (2.21-5.51)
Abdominal obesity 
Urban-Ghanaian 3.31 (1.99-5.52)
Amsterdam-Ghanaian 8.72 (5.41-14.07)  
Berlin-Ghanaian               7.43 (4.52-12.11)
London-Ghanaian 9.11 (5.55-14.95) 
Elevated triglycerides 
Urban-Ghanaian 1.39 (0.87-2.22)
Amsterdam-Ghanaian 2.38 (1.54-3.68)    
Berlin-Ghanaian 1.45 (0.88-2.39)
London-Ghanaian 1.81 (1.10-2.96)
Reduced HDL-C 
Urban-Ghanaian 0.72 (0.55-0.95)
Amsterdam-Ghanaian 0.67 (0.50-0.89)    
Berlin-Ghanaian 0.31 (0.21-0.47)
London-Ghanaian 0.62 (0.44-0.86)
Elevated blood pressure 
Urban-Ghanaian 1.43 (1.14-1.79)
Amsterdam-Ghanaian 2.11 (1.71-2.62)    
Berlin-Ghanaian 2.17 (1.71-2.73)
London-Ghanaian 2.01 (1.60-2.56)
Raised fasting glucose 
Urban-Ghanaian 1.53 (1.09-2.15)
Amsterdam-Ghanaian 2.88 (2.11-3.95)    
Berlin-Ghanaian 1.71 (1.19-2.47)
London-Ghanaian 1.85 (1.29-2.67)
Figure 2 Prevalence ratios (PRs) for metabolic syndrome and its components for men by site, compared with rural Ghana (reference
population, PR=1.00). Error bars are 95% confidence intervals. Model adjusted for age, level of education, physical activity and smoking status
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Reduced HDL-C
The age-adjusted prevalence of reduced HDL-C showed a negative
gradient from rural Ghana, through urban Ghana to Europe, in both
sexes, with the lowest prevalence of reduced HDL-C in Berlin-
Ghanaians (figure 1A and B ). The adjusted PRs followed a similar
pattern, with especially low PRs in Berlin- compared with rural-
Ghanaian men and women (figures 2 and 3). Within the
European sites, Berlin-Ghanaian men had a lower PR for reduced
HDL-C compared with Amsterdam-Ghanaian men (Supplementary
figure S1).
Elevated blood pressure
An elevated BP was more prevalent in Ghanaian migrants than par-
ticipants residing in Ghana (figure 1A and B). The adjusted PRs
showed a positive rural-urban-Europe gradient, with the PR being
twice as high in the European sites compared with rural Ghana
(figures 2 and 3). There were no differences in PRs between the
European sites.
Raised fasting plasma glucose
In men, the age-adjusted prevalence and adjusted PRs of raised FPG
showed a positive rural-to-urban gradient, with resembling prevalence
between urban Ghana and Europe. In women, the prevalence rates
were comparable between urban Ghana and London, and the adjusted
PRs did not differ between rural Ghana, Berlin and London. In
Europe, Amsterdam-Ghanaians had the highest prevalence of raised
FPG (figure 1A and B), which was reflected in the PRs
(Supplementary figure S1).
Discussion
Key findings
The MetSyn prevalence among Ghanaians differed by locality. In
men, the MetSyn prevalence showed a positive gradient from rural
Ghana, through urban Ghana to Europe, with a higher MetSyn
prevalence in Amsterdam-Ghanaian men. In women, there was a
positive gradient in MetSyn prevalence between rural- and urban-
Ghanaian women. However, this prevalence did not differ between
urban-Ghanaian women compared with their European-Ghanaian
counterparts.
The prevalence rates of the individual MetSyn components—except
for reduced HDL-C—were higher in urban Ghana compared with
rural Ghana, and even higher in Europe. A decreased HDL-C level
was more prevalent among rural-Ghanaians compared with their
urban and European counterparts. There was a high prevalence of
raised FPG in Amsterdam-Ghanaian men and women, which substan-
tially accounted for the lower MetSyn prevalence in Berlin-Ghanaians
compared with Amsterdam-Ghanaians.
Discussion of the key findings
The MetSyn prevalence showed a positive rural-to-urban gradient in
both sexes, which seems to suggest that exposure to an urban envir-
onment, potentiates the development of metabolic risk factors.20
This is in line with findings from other SSA studies.21–23
Moreover, MetSyn occurred at nearly the same rate among urban-
Ghanaian women compared with their European-Ghanaian coun-
terparts, suggesting that similar underlying processes might be at
play in urban areas in Ghana as in migrant populations in Europe.
The MetSyn prevalence is higher in Ghanaian migrant women
than in women from the respective European host populations,
whereas MetSyn is less prevalent in Ghanaian men compared with
European men.11,24,25 These results are in line with findings from the
USA, showing men from ethnic minorities being less affected by
MetSyn, whereas women from ethnic minorities being more
affected by MetSyn compared with the European descent
population.26 The differences in MetSyn prevalence rates between
the migrant and European host population is mostly attributable
to the high prevalence of abdominal obesity in Ghanaian
women.10,11,21,27 Genetic predisposition, differential exposures in
early life and gene-environmental interactions might contribute to
this disease susceptibility.12 Moreover, sociocultural perceptions
regarding ideal body size may also contribute to the high
abdominal obesity rate in women.28
The prevalence of raised FPG was remarkably higher among
Amsterdam-Ghanaian migrants compared with Berlin- and
London-Ghanaians and seems to be the major driving factor
behind the differences in MetSyn prevalence between these
European sites. These findings are in line with a previous study,
showing a raised FPG prevalence of 35 and 14% in non-diabetic
Amsterdam-African Caribbean’s and London-African Caribbean’s
respectively, despite a higher prevalence of central obesity in the
latter.10 The reason for the high susceptibility of Amsterdam-
Ghanaian migrants for having raised FPG is not clear, but might
be due to differences in contextual factors, such as differences in
access to health care and preventive services,29 psychosocial factors30
or dietary habits. Moreover, these contextual factors could initiate
epigenetic modifications, thereby shaping the glucose metabolism
differently among similar populations living in different countries.
Therefore, further research is required to clarify these intercountry
variations.
Another interesting finding of our study is the high prevalence of
reduced HDL-C in rural-Ghanaian residents, which showed to be
significantly higher in this group compared with the prevalence in
urban-Ghanaian and European-Ghanaian residents. These findings
are in line with previous reports from Ghana and other SSA
countries, demonstrating high prevalence rates of reduced HDL-C
in both rural and urban populations, with higher prevalence rates in
women than in men.7,23,31 These low levels of HDL-C in rural Ghana
might be due to specific dietary habits, which appear to differ from
the other geographical locations as previous RODAM results
showed.32 As HDL-C has a key role in the transport of excessive
cholesterol towards the liver for excretion, and has anti-thrombotic
and anti-inflammatory properties, it fulfils an important
cardioprotective role.33 Therefore, the high prevalence of reduced
HDL-C in the Ghanaian population points to a potential
important CVD risk factor and needs further research.
Strengths and limitations
This study is the first to look at MetSyn in a homogenous SSA
migrant population in comparison to the population in their
home country in SSA. Previous studies used migration surrogates
(e.g. comparing native Africans with African-Americans) to study
the effect of migration on CVD risk factors. However, people from
the African diaspora originate from heterogeneous ancestry and
show high levels of genetic diversity,34 which hampers the
comparison with populations residing in SSA. Moreover, none of
these migration studies focussed on MetSyn. The use of highly
standardized operating procedures for data collection across all
study sites made it possible to compare the different geographical
locations. However, as the RODAM study has a cross-sectional study
design, the possibilities to study the causality between MetSyn and
the determinants tested in the statistical models are limited. In
addition, as recruitment strategies had to be tailored to the
different study locations, a certain selection bias might have
occurred. However, as the non-response analysis revealed similar
patterns between all sites, we consider it unlikely that the differences
in prevalence rates between the sites are biased by the variations in
sampling strategy. As we performed full case analysis, participants
with missing data on education, smoking or physical activity were
excluded from the Poisson regression analysis. However, the partici-
pants excluded from analysis did not differ from those included, in
terms of age or sex. In addition, those with missing data did not
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differ from those with complete data with regards to prevalence of
MetSyn or its components. Therefore, we do not expect missing data
on these covariates to influence our results in a significant way.
Lastly, different methods were used to administer the questionnaire,
which could introduce some level of bias as varied methods could
have influenced the participants’ answers differently. However, only
small percentage of Ghanaian migrants in Europe (12%) self-admin-
istered the questionnaire. In addition, as research assistants were
trained to conduct the interviews in a standardized way, we
consider this limitation to be a minor source of bias.
Conclusion
Our findings show a positive gradient of the MetSyn prevalence
from rural Ghana, through urban Ghana to Europe but only in
men. The prevalence rates of the individual MetSyn components
(abdominal obesity, elevated triglyceride, elevated BP and raised
FPG) generally show positive gradients whereas reduced HDL-C
shows a negative gradient from rural Ghana, through urban
Ghana to Europe. In addition, the prevalence of MetSyn and its
components vary among Ghanaian migrants living in different
European countries. These distinctive geographical differences
between the groups show the potential importance of contextual
factors on cardiometabolic risk and suggest the need to unravel
the underlying mechanisms to guide prevention management
efforts in SSA populations.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Metabolic syndrome (MetSyn) is an important risk factor
for cardiovascular diseases and type 2 diabetes. It is
unknown whether the rate of metabolic syndrome differs
between rural and urban settings in Africa and upon
migration to Europe.
 This study shows a positive rural-to-urban gradient in
MetSyn prevalence in both men and women, and a higher
prevalence in European- than in urban-Ghanaian men, but
no differences in prevalence between urban-Ghanaian and
European-Ghanaian women.
 The prevalence rates of the individual MetSyn
components—except for reduced HDL-C—are higher in
urban Ghana compared with rural Ghana, and even higher
in Europe; reduced HDL-C is more prevalent in rural Ghana
than in the other geographical locations.
 Difference in MetSyn prevalence between the European sites
is mostly attributable to the high prevalence of raised fasting
plasma glucose in Amsterdam-Ghanaians.
 To assist preventive efforts, further research is needed to
understand mechanisms driving the geographical differences
in MetSyn prevalence.
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